These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37012275)

  • 21. A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents
    Débare H; Moiré N; Baron F; Lantier L; Héraut B; Van Langendonck N; Denevault-Sabourin C; Dimier-Poisson I; Debierre-Grockiego F
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach.
    Ashwinder K; Kho MT; Chee PM; Lim WZ; Yap IK; Choi SB; Yam WK
    Interdiscip Sci; 2016 Dec; 8(4):374-387. PubMed ID: 26297309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
    Moine E; Dimier-Poisson I; Enguehard-Gueiffier C; Logé C; Pénichon M; Moiré N; Delehouzé C; Foll-Josselin B; Ruchaud S; Bach S; Gueiffier A; Debierre-Grockiego F; Denevault-Sabourin C
    Eur J Med Chem; 2015 Nov; 105():80-105. PubMed ID: 26479029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.
    Sharma H; Landau MJ; Sullivan TJ; Kumar VP; Dahlgren MK; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1232-5. PubMed ID: 24440298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice.
    Azimi-Resketi M; Eskandarian A; Ganjalikhani-Hakemi M; Zohrabi T
    Acta Trop; 2020 Jul; 207():105488. PubMed ID: 32277926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase.
    Radke JB; Melillo B; Mittal P; Sharma M; Sharma A; Fu Y; Uddin T; Gonse A; Comer E; Schreiber SL; Gupta AK; Chatterjee AK; Sibley LD
    Nat Commun; 2022 Jan; 13(1):459. PubMed ID: 35075105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents.
    Luan T; Jin C; Jin CM; Gong GH; Quan ZS
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):761-772. PubMed ID: 30836795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation.
    Zhang P; Jia L; Tian Y; Xi L; Duan R; Chen X; Xiao J; Yao X; Lan J; Li S
    Chem Biol Drug Des; 2020 May; 95(5):476-484. PubMed ID: 31436911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.
    Moine E; Moiré N; Dimier-Poisson I; Brunet K; Couet W; Colas C; Van Langendonck N; Enguehard-Gueiffier C; Gueiffier A; Héraut B; Denevault-Sabourin C; Debierre-Grockiego F
    Int J Parasitol; 2018 Jun; 48(7):561-568. PubMed ID: 29524527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening.
    Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J
    Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18.
    Molina D; Cossio-Pérez R; Rocha-Roa C; Pedraza L; Cortes E; Hernández A; Gómez-Marín JE
    BMC Genomics; 2018 Nov; 19(1):856. PubMed ID: 30497375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
    Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
    Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach.
    Vetrivel U; Nagarajan H
    Life Sci; 2018 Nov; 213():82-93. PubMed ID: 30326220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
    Gangjee A; Adair O; Queener SF
    J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.